These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17698614

  • 1. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.
    Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM.
    Diabetes Care; 2007 Nov; 30(11):2874-9. PubMed ID: 17698614
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults: response to Hoerger et al.
    Wechowski JW.
    Diabetes Care; 2008 May; 31(5):e34; author reply e35. PubMed ID: 18445714
    [No Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
    Icks A, Rathmann W, Haastert B, John J, Löwel H, Holle R, Giani G, KORA Study Group.
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S167-71. PubMed ID: 16032536
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate.
    Mobley LR, Hoerger TJ, Wittenborn JS, Galuska DA, Rao JK.
    Med Decis Making; 2006 Aug; 26(2):194-206. PubMed ID: 16525173
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of a family-based GP-mediated intervention targeting overweight and moderately obese children.
    Moodie M, Haby M, Wake M, Gold L, Carter R.
    Econ Hum Biol; 2008 Dec; 6(3):363-76. PubMed ID: 18657487
    [Abstract] [Full Text] [Related]

  • 7. Cost effectiveness of community-based physical activity interventions.
    Roux L, Pratt M, Tengs TO, Yore MM, Yanagawa TL, Van Den Bos J, Rutt C, Brownson RC, Powell KE, Heath G, Kohl HW, Teutsch S, Cawley J, Lee IM, West L, Buchner DM.
    Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
    [Abstract] [Full Text] [Related]

  • 8. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M, Szafraniec K, Gilis-Januszewska A, Pach D, Krzentowska A, Szybiński Z, Huszno B.
    Przegl Lek; 2006 Dec; 63(9):728-32. PubMed ID: 17479858
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany.
    Schaufler TM, Wolff M.
    Appl Health Econ Health Policy; 2010 Dec; 8(3):191-202. PubMed ID: 20408603
    [Abstract] [Full Text] [Related]

  • 11. Economic analysis of a school-based obesity prevention program.
    Wang LY, Yang Q, Lowry R, Wechsler H.
    Obes Res; 2003 Nov; 11(11):1313-24. PubMed ID: 14627751
    [Abstract] [Full Text] [Related]

  • 12. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM, Incani M, Pilia S, Congiu T, Cavallo MG, Cossu E, Sentinelli F, Mariotti S, Loche S, Baroni MG.
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [Abstract] [Full Text] [Related]

  • 13. Economic evaluation of weight loss interventions in overweight and obese women.
    Roux L, Kuntz KM, Donaldson C, Goldie SJ.
    Obesity (Silver Spring); 2006 Jun; 14(6):1093-106. PubMed ID: 16861615
    [Abstract] [Full Text] [Related]

  • 14. The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action.
    Bemelmans W, van Baal P, Wendel-Vos W, Schuit J, Feskens E, Ament A, Hoogenveen R.
    Prev Med; 2008 Feb; 46(2):127-32. PubMed ID: 17822752
    [Abstract] [Full Text] [Related]

  • 15. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective.
    Lindgren P, Lindström J, Tuomilehto J, Uusitupa M, Peltonen M, Jönsson B, de Faire U, Hellénius ML, DPS Study Group.
    Int J Technol Assess Health Care; 2007 Feb; 23(2):177-83. PubMed ID: 17493303
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population.
    Lü Q, Tong N, Liu Y, Li N, Tang X, Zhao J, Cao H, Li D, Gou L, Zhang Y, Wan J, Jiang L.
    Diabetes Res Clin Pract; 2009 Jun; 84(3):319-24. PubMed ID: 19442860
    [Abstract] [Full Text] [Related]

  • 18. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J.
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [Abstract] [Full Text] [Related]

  • 19. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [Abstract] [Full Text] [Related]

  • 20. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
    Xie F, O'Reilly D, Ferrusi IL, Blackhouse G, Bowen JM, Tarride JE, Goeree R.
    J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.